Post-PCI corrected TIMI Frame Count predicts left ventricular global longitudinal strain at 90 days post-STEMI in thrombolysis-treated patients: A pre-specified analysis of the MIRTOS study

Post-PCI corrected TIMI Frame Count predicts left ventricular global longitudinal strain at 90 days post-STEMI in thrombolysis-treated patients: A pre-specified analysis of the MIRTOS study

Introduction: Ticagrelor has been established as the P2Y12-inhibitor of choice in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI); however, its use has not been adequately studied in the context of thrombolysis. In the present s...

Full description

Bibliographic Details
Main Authors: Ioannis Anastasiou, Alexandros Patrianakos, Michail Vernardos, Emmanouil Foukarakis, Michail Pitarokoilis, Stylianos Petousis, Evangelos Zacharis, Maria Marketou, Emmanouil Skalidis, George Kochiadakis, Fragkiskos Parthenakis, Panos Vardas, Michalis Hamilos
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:American Heart Journal Plus
Subjects:
STEMI
Clopidogrel
Ticagrelor
LVEF
LV-GLS
Thrombolysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602222001392

Internet

http://www.sciencedirect.com/science/article/pii/S2666602222001392

Similar Items